PYC Therapeutics Investor Relations Material
Latest events
Q1 2025
PYC Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from PYC Therapeutics Limited
Access all reports
PYC Therapeutics Limited is an Australia-based biotechnology company focused on developing RNA-based therapies to treat genetic diseases. The company specializes in precision medicine, leveraging its RNA therapeutic platform to design and deliver drugs targeting the root causes of genetic disorders. PYC Therapeutics is involved in preclinical and clinical development, with a focus on rare inherited diseases, particularly those affecting vision and the central nervous system. The company is headquartered in Perth, Western Australia, and its shares are listed on the ASX.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
PYC
Country
🇦🇺 Australia